Article

Impact of DNA methylation on the recurrence risk of stage I non-small cell lung cancer with EGFR mutations

2025-05-06

Abstract excerpt

<title>Abstract</title> <p>Background Recent studies have demonstrated that patients with stage IB-IIIA non-small cell lung cancer (NSCLC) harboring EGFR mutations (EGFRm) can significantly benefit from adjuvant therapy with EGFR-TKIs. Nevertheless, there is remains controversial in clinical practice about the use of EGFR-TKI adjuvant therapy for patients with stage IB EGFRm NSCLC. Methods This retrospective co...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4ea9c037-1841-514b-a90f-b0c935dd09b0
DOI: 10.21203/rs.3.rs-5808504/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Impact of DNA methylation on the recurrence risk of stage I non-small cell lung cancer with EGFR mutationsDOI 10.21203/rs.3.rs-5808504/v1Read

DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical managementSemantic proximity Read

Clinical, Pathologic, and Molecular Prognostic Factors in Patients with Early-Stage EGFR-Mutant NSCLC.Semantic proximity Read

Genetic variations in epigenetic genes are predictors of recurrence in stage I or II non-small cell lung cancer patients.Semantic proximity Read

Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancerSemantic proximity Read

A molecule based nomogram optimized the prediction of relapse in stage I NSCLCSemantic proximity Read

EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system.Semantic proximity Read

A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung CancerSemantic proximity Read

EGFR Mutation Impacts Recurrence in High-Risk Early-Stage Lung Adenocarcinoma in the IASLC Grading SystemSemantic proximity Read

Monitoring EGFR-lung cancer evolution: a possible beginning of a “methylation era” in TKI resistance predictionSemantic proximity Read

A risk score system based on DNA methylation levels and a nomogram survival model for lung squamous cell carcinomaSemantic proximity Read

Risk stratification and adjuvant chemotherapy after radical resection based on the clinical risk scores of patients with stage IB-IIA non-small cell lung cancer.Semantic proximity Read

Risk Stratification and Adjuvant Chemotherapy Based on Clinical Risk Scores of Patients with Stage IB-IIA Non-Small Cell Lung CancerSemantic proximity Read